Hubbry Logo
Ochratoxin AOchratoxin AMain
Open search
Ochratoxin A
Community hub
Ochratoxin A
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Ochratoxin A
Ochratoxin A
Ochratoxin A
View on Wikipedia
from Wikipedia

Ochratoxin A
Names
IUPAC name
N-[(3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carbonyl]-L-phenylalanine
Systematic IUPAC name
(2S)-2-[(3R)-5-Chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carboxamido]-3-phenylpropanoic acid
Other names
(R)-N- [(5-Chloro- 3,4-dihydro- 8-hydroxy- 3-methyl- 1-oxo- 1H-2-benzopyran-7-yl) -carbonyl]- L- phenylalanine
(−)-N- [(5-Chloro- 8-hydroxy- 3-methyl- 1-oxo- 7-isochromanyl) carbonyl]- 3-phenylalanine
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard 100.005.586 Edit this at Wikidata
EC Number
  • 206-143-7
KEGG
UNII
UN number 2811
  • InChI=1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 checkY
    Key: RWQKHEORZBHNRI-BMIGLBTASA-N checkY
  • InChI=1/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1
    Key: RWQKHEORZBHNRI-BMIGLBTABQ
  • O=C(O)[C@@H](NC(=O)c1c(O)c2c(c(Cl)c1)C[C@H](OC2=O)C)Cc3ccccc3
Properties
C20H18ClNO6
Molar mass 403.813
Melting point 169 °C (336 °F; 442 K)
Hazards
GHS labelling:[1]
GHS06: ToxicGHS07: Exclamation markGHS09: Environmental hazard
Danger
H300, H351, H413
P203, P260, P264, P264+P265, P270, P271, P273, P280, P284, P301+P316, P304+P340, P305+P351+P338, P316, P318, P320, P321, P330, P337+P317, P403+P233, P405, P501
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Ochratoxin A—a toxin produced by different Aspergillus and Penicillium species—is one of the most-abundant food-contaminating mycotoxins.[1] It is also a frequent contaminant of water-damaged houses and of heating ducts.[2][3] Human exposure can occur through consumption of contaminated food products, particularly contaminated grain and pork products, as well as coffee, wine grapes, and dried grapes.[4][5][6] The toxin has been found in the tissues and organs of animals, including human blood and breast milk.[7] Ochratoxin A, like most toxic substances, has large species- and sex-specific toxicological differences.[5]

Impact on human and animal health

[edit]

Carcinogenicity

[edit]

Ochratoxin A is potentially carcinogenic to humans (Group 2B), and has been shown to be weakly mutagenic, possibly by induction of oxidative DNA damage.[8]

The evidence in experimental animals is sufficient to indicate carcinogenicity of ochratoxin A. It was tested for carcinogenicity by oral administration in mice and rats. It slightly increased the incidence of hepatocellular carcinomas in mice of each sex.[9] and produced renal adenomas and carcinomas in male mice and in rats (carcinomas in 46% of males and 5% of females).[10] In humans, very little histology data is available, so a relationship between ochratoxin A and renal cell carcinoma has not been found. However, the incidence of transitional cell (urothelial) urinary cancers seems abnormally high in Balkan endemic nephropathy patients, especially for the upper urinary tract.[11] The molecular mechanism of ochratoxin A carcinogenicity has been under debate due to conflicting literature, however this mycotoxin has been proposed to play a major role in reducing antioxidant defenses.[12]

Neurotoxicity

[edit]

Ochratoxin A has a strong affinity for the brain, especially the cerebellum (Purkinje cells), ventral mesencephalon, and hippocampal structures.[13] The affinity for the hippocampus could be relevant to the pathogenesis of Alzheimer's disease, and subchronic administration to rodents induces hippocampal neurodegeneration. Ochratoxin causes acute depletion of striatal dopamine, which constitutes the bed of Parkinson's disease, but it did not cause cell death in any of brain regions examined.[14] Teams from Zheijiang Univ. and Kiel Univ. hold that ochratoxin may contribute to Alzheimer's and to Parkinson's diseases. Nonetheless, their study was performed in vitro and may not extrapolate to humans.[15] The developing brain is very susceptible to ochratoxin, hence the need for caution during pregnancy.[16]

Immunosuppression and immunotoxicity

[edit]

Ochratoxin A can cause immunosuppression and immunotoxicity in animals. The toxin's immunosuppressant activity in animals may include depressed antibody responses, reduced size of immune organs (such as the thymus, spleen, and lymph nodes), changes in immune cell number and function, and altered cytokine production. Immunotoxicity probably results from cell death following apoptosis and necrosis, in combination with slow replacement of affected immune cells due to inhibition of protein synthesis.[1]

[edit]

Balkan endemic nephropathy (BEN), a slowly progressive renal disease, appeared in the middle of the 20th century, highly localized around the Danube, but only hitting certain households. Patients over the years develop kidney failure that requires dialysis or transplantation. The initial symptoms are those of a tubulointerstitial nephritis of the sort met with after toxic aggressions to the proximal convoluted tubules. Such proximal tubule nephropathies can be induced by aluminium (e.g. in antiperspirants), antibiotics (vancomycin, aminosides), tenofovir (for AIDS), and cisplatin[citation needed]. Their symptoms are well known to nephrologists: glycosuria without hyperglycemia, microalbuminuria, poor urine concentration capacity, impaired urine acidification, and yet long-lasting normal creatinine clearance.[17] In BEN, renal biopsy shows acellular interstitial fibrosis, tubular atrophy, and karyomegaly in proximal convoluted tubules.[18] A number of descriptive studies have suggested a correlation between exposure to ochratoxin A and BEN, and have found a correlation between its geographical distribution and a high incidence of, and mortality from, urothelial urinary tract tumours.[19] However, insufficient information is currently available to conclusively link ochratoxin A to BEN.[20] The toxin may require synergistic interactions with predisposing genotypes or other environmental toxicants to induce this nephropathy.[21] Ochratoxin possibly is not the cause of this nephropathy, and many authors are in favor of aristolochic acid, that is contained in a plant: birthwort (Aristolochia clematitis). Nevertheless, although many of the pieces of scientific evidence are lacking and/or need serious re-evaluation, it remains that ochratoxin, in pigs, demonstrates direct correlation between exposure and onset and progression of nephropathy.[22] This porcine nephropathy[23] bears typical signs of toxicity to proximal tubules: loss of ability to concentrate urine, glycosuria, and histological proximal tubule degeneration.

Other nephropathies, although not responding to the "classical" definition of BEN, may be linked to ochratoxin. Thus, this could in certain circumstances be the case for focal segmental glomerulosclerosis after inhalational exposure: such a glomerulopathy with noteworthy proteinuria has been described[24] in patients with very high urinary ochratoxin levels (around 10 times levels that can be met with in "normal" subjects, i.e. around 10 ppb or 10 ng/ml).

Food animal industry impact

[edit]

Ochratoxin-contaminated feed has its major economic impact on the poultry industry. Chickens, turkeys, and ducklings are susceptible to this toxin. Clinical signs of avian ochratoxicosis generally involve reduction in weight gains, poor feed conversion, reduced egg production, and poor egg shell quality.[25] Economic losses occur also in swine farms, linked to nephropathy and costs for the disposal of carcasses.

Toxicity does not seem to constitute a problem in cattle, as the rumen harbors protozoa that hydrolyze OTA.[26] However, contamination of milk is a possibility.[citation needed]

Dietary guidelines

[edit]
Concentrations of ochratoxin in usual foods
Source Median
in μg/kg
of food 		Median
in ng/kg
of food 		Weight
in kg 		Diet 1 Diet 1+
Liquorice extract 26.30 26,300
Ginger 5.50 5,500 0.005 27.50
Nutmeg 2.27 2,265 0.005 11.33
Paprika 1.32 1,315 0.005 6.58
Pig liver 1.10 1,100
Ginseng 1.10 1,100
Raisins dry 0.95 950 0.1 95.00
Pig kidney 0.80 800 0.2 160
Liquorice confectionery 0.17 170
Coffee 0.13 125 0.3 37.50
Cereals 0.09 87.5 0.5 43.75
Peanuts 0.08 79 0.2 15.80
Wine 0.05 50 0.5 25
Pulses 0.05 49.5 0.5 24.75
Beer 0.05 49
Salami 0.05 49 0.3 14.70
Total in ng 286.11 461.91

EFSA established in 2006 the "tolerable weekly intake" (TWI) of ochratoxin A (on advice of the Scientific Panel on Contaminants in the Food Chain) at 120 ng/kg.,[27] equivalent to a tolerable daily intake (TDI) of 14 ng/kg. Other organizations have established even lower limits for intake of ochratoxin A, based on the consumption habits of the population.[28] For USA, the FDA considers a TDI of 5 ng/kg. In the US, mean body weight for men is 86 kg, and for women 74 kg.[citation needed] Hence, the TDI for men is 430 ng and for women is 370 ng. In the joined table "weight in kg" is the weight eaten per day of each of the listed foodstuffs. Diet 1, with small quantities of ginger, nutmeg, and paprika, a good serving of dry raisins, a reasonable amount of coffee, cereals, wine, pulses, and salami, amounts to a safe diet (as for ochratoxin, at least), with 286 ng per day. However, it would be easy to go into excessive levels (Diet 1+), just by eating 200 g of pig kidney and 200 g of peanuts, which would lead to a total of nearly 462 ng of ochratoxin. This shows how delicate a safe diet can be.

Tolerable daily intake 5 ng/kg
Gender Weight
in kg 		Tolerable OTA
in ng
male 86 430
female 74 370

Although ochratoxin A is not held as of today as responsible for renal cell carcinoma (RCC), the most frequent renal cancer, it is frequently written that dietary pattern might decrease or increase the risk of RCC. A Uruguayan case-control study [29] correlates intake of meat with occurrence of RCC. A very large prospective cohort in Sweden [30] explores correlations between RCC occurrence, diets rich in vegetables and poultry (so-called "healthy diets"), and diets rich in meat (especially processed meat: salami, black pudding). The thesis defended is that more fruit and vegetables might have a protective role. Fruit (except raisins and dried fruit) are very poor in ochratoxin, and processed meat can be rich in ochratoxin.

Dermal exposure

[edit]

Ochratoxin A can permeate through the human skin.[31] Although no significant health risk is expected after dermal contact in agricultural or residential environments, skin exposure to ochratoxin A should nevertheless be limited.

Genetic resistance

[edit]

In 1975, Woolf et al.[32] proposed that the inherited disorder phenylketonuria protects against ochratoxin A poisoning through the production of high levels of phenylalanine. Ochratoxin is a competitive inhibitor of phenylalanine in the phenylalanyl-tRNA-synthetase-catalyzed reaction thus preventing protein synthesis, which can be reversed by introducing phenylalanine, which is in excess in PKU individuals.[33]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Ochratoxin A

View on Grokipedia
from Grokipedia
Ochratoxin A (OTA) is a potent and ubiquitous mycotoxin produced by certain species of Aspergillus and Penicillium fungi, including A. ochraceus, A. carbonarius, A. niger, and P. verrucosum, under warm and humid conditions during crop storage or processing. Chemically, OTA consists of a para-chlorophenolic isocoumarin moiety linked to L-phenylalanine via an amide bond, with a molecular formula of C₂₀H₁₈ClNO₆ and a molecular weight of 403.8 Da, rendering it stable and persistent in food matrices. First identified in 1965 as a toxic metabolite from A. ochraceus in moldy cornmeal, OTA contaminates a wide array of commodities worldwide, including cereals, coffee beans, dried fruits, wine, pork products, and spices, with reported levels ranging from trace amounts to over 27,000 ng/g in severely affected samples. OTA's primary toxicity targets the kidneys, where it accumulates and induces through mechanisms such as inhibition of protein synthesis, mitochondrial dysfunction, , and formation, leading to tubular degeneration and fibrosis in animal models. In humans, chronic exposure has been associated with (BEN) and urinary tract tumors, particularly in regions with high contamination like the , though causal links remain under investigation; it also exhibits immunotoxic, genotoxic, and potential teratogenic effects. The International Agency for Research on Cancer (IARC) classifies OTA as a Group 2B possible human carcinogen based on sufficient evidence in experimental animals and limited human data. Recent assessments confirm its genotoxic potential via direct DNA damage, prompting stricter exposure limits. Regulatory bodies have established guidelines to mitigate risks, with the (EFSA) establishing a tolerable weekly intake of 120 ng/kg body weight in 2006, which was withdrawn in 2020 due to and carcinogenicity concerns; a Margin of Exposure approach is now used to assess risks, and maximum levels in foods like raw grains (5 µg/kg), roasted beans and ground roasted (3 µg/kg), and soluble (5 µg/kg). The emphasizes prevention through proper and storage of crops, discarding moldy , and dietary diversification to limit intake, as OTA's stability makes complete elimination challenging during . Ongoing research focuses on strategies, such as microbial degradation and adsorbents, to reduce contamination in the .

Chemical Properties

Molecular Structure

Ochratoxin A (OTA) is characterized by the molecular formula \ceC20H18ClNO6\ce{C20H18ClNO6} and a molecular weight of 403.81 g/mol. The molecule is a hybrid structure consisting of a β\beta-phenyl-γ\gamma-L-phenylalanine moiety linked via an bond to a 3,4-dihydro-3-methyl-8-hydroxy-6-methoxy-isocoumarin unit, with a chlorine atom substituted at the para position of the phenyl ring. This arrangement includes key functional groups such as a lactone ring in the isocoumarin portion, a carboxylic acid at the phenylalanine terminus, and the linkage that connects the two domains. The full IUPAC name reflects this complexity: (2S)-2-[[(3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydroisochromene-7-carbonyl]amino]-3-phenylpropanoic acid. OTA features two chiral centers, with the (3R) configuration at the 3-position of the dihydroisocoumarin ring and the (2S) configuration in the L-phenylalanine-derived portion. The L-phenylalanine stereochemistry is essential for OTA's biological potency, as diastereomers and enantiomers with modified configurations at this site demonstrate significantly diminished cytotoxicity in cellular assays. Among related ochratoxins, ochratoxin B serves as the non-chlorinated analog of OTA, differing only by the absence of the chlorine substituent and exhibiting lower toxicity due to this structural variation. In contrast, ochratoxin C is the ethyl ester form of OTA, where the carboxylic acid group is esterified, enhancing lipophilicity but retaining core structural similarities to the parent compound.

Physical and Chemical Characteristics

Ochratoxin A appears as a white to off-white crystalline powder. Its key physical properties include a of 169°C. The compound exhibits low in , approximately 0.00042 mg/mL (0.42 mg/L) at 25°C, but shows higher solubility in polar organic solvents such as (up to 10 mg/mL), , acetone, and . This solubility profile influences its extraction and detection in contaminated matrices. Ochratoxin A demonstrates chemical stability under acidic and neutral conditions, with high stability during heat treatments like autoclaving at 121°C, showing negligible degradation even after prolonged exposure (e.g., 3 hours). It degrades more readily under alkaline conditions, with up to 50% removal observed, and at high temperatures exceeding 200°C, where partial occurs. The compound is relatively stable to in solid form but sensitive to UV light and direct sunlight in solution, leading to of its ring. The pKa values of ochratoxin A are approximately 4.4 for the group and 7.1 for the phenolic hydroxyl group, which affect its state and in different environments. These values stem from its molecular structure, featuring an linked to L-phenylalanine.

Biosynthesis and Producing Organisms

Fungal Producers

Ochratoxin A (OTA) was first isolated in 1965 as a toxic metabolite produced by the fungus ochraceus from cultures grown on sterile meal during investigations in . This discovery, reported by van der Merwe and colleagues, identified OTA as a responsible for nephrotoxic effects observed in animal models exposed to fungal cultures. The primary fungal producers of OTA belong to the genera and , with approximately 20 confirmed as capable of across these groups. Key include A. ochraceus, A. carbonarius, A. niger, and A. westerdijkiae, while prominent are P. verrucosum and P. nordicum. These fungi are ubiquitous saprophytes and opportunistic pathogens that colonize materials post-harvest. Aspergillus species predominate in tropical and subtropical regions, thriving on commodities like , grapes, and cereals in warmer climates, whereas Penicillium species are more prevalent in temperate and cooler areas, often contaminating stored grains such as and . For instance, A. carbonarius is a major OTA producer in Mediterranean vineyards, while P. verrucosum is the dominant source in European cereal stores. OTA-producing strains generally favor warm, humid environments with levels above 0.88 and temperatures between 15–30°C, though optimal conditions vary by species.

Biosynthetic Pathway

Ochratoxin A (OTA) biosynthesis in producing fungi proceeds via a hybrid polyketide-nonribosomal peptide pathway, initiating with the polyketide synthase (PKS)-mediated assembly of the isocoumarin moiety from and units, followed by oxidative modifications and bond formation with L-phenylalanine. The PKS enzyme catalyzes the iterative condensation to form a dihydroisocoumarin intermediate, specifically 7-methylmellein, which is then oxidized to 7-hydroxymellein (OTβ) by a monooxygenase. Subsequently, a nonribosomal peptide synthetase (NRPS) facilitates the coupling of OTβ with L-phenylalanine to yield ochratoxin B (OTB), which undergoes chlorination at the para position of the phenyl ring to produce OTA. This pathway is conserved across OTA-producing species, reflecting a modular enzymatic that integrates polyketide chain elongation with ligation. Key enzymes in the pathway include the multifunctional PKS (OtaA), which incorporates domains such as ketosynthase (KS) for carbon-carbon bond formation, acyltransferase (AT) for loading, and dehydratase for intermediate processing, culminating in the release of the product via a thioesterase domain. The NRPS (OtaB) contains adenylation, peptidyl carrier protein, and domains to selectively activate and couple L-phenylalanine to OTβ, with its thioesterase domain enabling product release as OTB. Chlorination is mediated by a flavin-dependent halogenase (OtaD), which installs the atom on the phenylalanine-derived moiety post-coupling, while the P450 (OtaC) performs the essential step. These enzymes operate in a coordinated manner, with the coupling preceding chlorination, as evidenced by disruption studies. The OTA biosynthetic pathway is encoded by a compact comprising four core structural s—otaA (PKS), otaB (NRPS-thioesterase), otaC (), and otaD (halogenase)—along with regulatory elements, identified in both and species such as A. ochraceus, A. carbonarius, and P. nordicum. This orthologous cluster spans approximately 7-10 kb and is flanked by transporter and pathway-specific regulator genes, with otaA serving as the hallmark PKS gene for cluster delineation. has revealed high sequence conservation (>80% identity) among these genes across genera, though clusters often include additional tailoring enzymes. experiments in model strains have confirmed the essential roles of each component in OTA production. Regulation of the OTA biosynthetic cluster is primarily governed by environmental cues and transcriptional activators within the producing fungi. The bZIP transcription factor OtaR1 positively regulates the otaA-otaD core genes, while OtaR2 fine-tunes expression of otaA, otaC, and otaD under stress conditions. External factors such as (optimal at 5.0-6.5, mediated by the PacC pH-response regulator), (peaking at 25-30°C), and availability (enhanced by as a carbon source and organic , repressed by via CreA and AreA mediators) modulate cluster expression through signaling pathways like HOG for osmolarity. These influences integrate with global regulators to control OTA output during fungal growth.

Occurrence in Food and Environment

Contaminated Commodities

Ochratoxin A (OTA) contamination is prevalent in grains such as , , oats, and corn, particularly in stored products where levels can reach up to 100 µg/kg under suboptimal conditions. Surveys have detected OTA in 15-70% of samples, with concentrations often ranging from 0.1 to 5 µg/kg in processed forms, though exceedances of the maximum limit of 5 µg/kg occur in unprocessed grains like and (3 µg/kg for processed products). This contamination primarily arises from fungal growth during storage, affecting both and supplies. Note that EU maximum levels were updated in 2022, lowering limits for several products including processed cereals (to 3 µg/kg). In beverages, OTA frequently contaminates wine derived from grapes, especially in European regions where surveys indicate presence in 20-85% of samples at levels of 0.09-1.5 µg/L, with up to 20% exceeding the limit of 2 µg/L in certain types of wines. , particularly green beans infected by species, shows OTA levels from 0.4 to 50 µg/kg, reducing slightly upon but remaining a notable source ( limit for roasted coffee: 3 µg/kg for beans/ground, 5 µg/kg for instant, as updated in 2022). , sourced from contaminated , contains OTA in 45% of samples at 0.04-0.35 µg/L, transferred during processes. Animal products, including and , exhibit OTA carryover from contaminated feed, with highest concentrations in organs like kidneys and livers. In , OTA levels range from 0.1 to 0.8 µg/kg in muscle but up to 23 µg/kg in kidneys, while poultry kidneys show 0.9-23 µg/kg, posing risks in supply chains. This occurs in species like pigs and chickens fed OTA-tainted grains. Other commodities such as dried fruits, spices, and cocoa are also affected, with OTA levels in dried fruits reaching up to 10 µg/kg (though the current limit is 2 µg/kg, updated in 2022), spices like and pepper reaching 15 µg/kg ( limit: 15 µg/kg), and cocoa beans showing variable contamination during processing and storage. Environmentally, OTA persists in and airborne dust, linked to fungal spores from agricultural residues. Globally, OTA incidence is higher in developing regions due to inadequate storage practices, leading to elevated levels in staples like cereals and contributing to greater dietary exposure compared to regulated areas in and .

Factors Influencing Production

The production of ochratoxin A (OTA) by toxigenic fungi such as species of and is modulated by a range of environmental and biological conditions that influence fungal growth and . These factors determine the onset and extent of OTA synthesis, often peaking under suboptimal conditions for fungal proliferation but favorable for toxin accumulation. Abiotic conditions play a central role in OTA production. Temperature optima vary by species, with Aspergillus carbonarius and A. niger favoring 25–30°C, while A. ochraceus produces maximally at 20–30°C. (a_w) is critical, with OTA synthesis occurring between 0.87–0.99 a_w but optimizing at 0.95–0.99 for most producers, such as P. verrucosum on grain where levels drop sharply below 0.90 a_w. Relative exceeding 80% further promotes fungal sporulation and toxin elaboration by maintaining high a_w in substrates. Acidic environments, typically 4–6, enhance production, with peaks for A. carbonarius and A. niger at pH 5.0–6.5 and for P. citrinum at pH 5. Substrate composition significantly affects OTA yields, as nutrient availability directs metabolic pathways toward secondary metabolites. Carbon sources like , , and glucose at 6% concentration stimulate biosynthesis in A. niger, with yielding up to 21.93 µg/g dry hyphae, whereas nitrogen-rich peptone inhibits it. Nutrient-dense media such as grains (e.g., corn, ) or fruit-based substrates (e.g., grapes) support higher OTA levels compared to simpler media, due to enhanced fungal biomass and activity. Optimal in these substrates often shifts during growth as glucose catabolism acidifies the medium, further favoring OTA accumulation. Biotic interactions and stress responses also upregulate OTA production. Competition among microbial communities can alter toxin levels, with certain indigenous fungi reducing OTA output from P. verrucosum and P. nordicum through resource competition or antagonism. , marked by elevated anions and alongside reduced and activity, triggers OTA synthesis via gene upregulation (e.g., pks, nrps) in A. niger. Similarly, osmotic stress from high NaCl concentrations activates the high osmolarity (HOG) pathway in P. nordicum, increasing OTA as an adaptive response. Post-harvest conditions exacerbate OTA risks by creating conducive microenvironments for fungal proliferation. Inadequate ventilation and control in storage facilities elevate and a_w, promoting mold growth and toxin production in crops like cereals. contributes by expanding warmer, humid regions suitable for species, thereby increasing OTA incidence in temperate zones shifting toward subtropical climates.

Toxicity and Health Effects

Mechanisms of Toxicity

Ochratoxin A (OTA) is rapidly absorbed from the following oral exposure, with ranging from 40% to 80% in various species, and is distributed primarily to the kidneys and liver due to its affinity for plasma proteins such as . In the kidneys, OTA undergoes active uptake via organic anion transporters (OATs), including OAT1, OAT3, and OAT4, which facilitate its and in proximal tubules, contributing to its accumulation. The of OTA exhibit linear characteristics over typical exposure ranges, with a notably long elimination half-life of approximately 35 days in humans, attributed to extensive protein binding that slows clearance. The primary mechanism of OTA toxicity involves inhibition of protein synthesis through competitive binding to phenylalanyl-tRNA synthetase (PheRS), an enzyme essential for attaching to its cognate tRNA. This inhibition arises from OTA's structural resemblance to , as OTA consists of a dihydroisocoumarin moiety linked via an bond to L-β-phenylalanine, allowing it to mimic the amino acid substrate and disrupt elongation at the ribosomal level. Studies in bacterial and mammalian systems have confirmed that OTA reduces PheRS activity in a dose-dependent manner, leading to impaired cellular without affecting other synthetases significantly. OTA also induces oxidative stress by generating reactive oxygen species (ROS), which trigger lipid peroxidation and oxidative DNA damage in affected cells. This process is mediated in part by the depletion of cellular antioxidants, such as , and inhibition of Nrf2 signaling pathways, exacerbating the imbalance between oxidant production and . In vitro models demonstrate that OTA exposure elevates markers of oxidative damage, including and , underscoring ROS as a key contributor to its cytotoxic effects. Bioactivation of OTA occurs primarily through cytochrome P450 enzymes (e.g., and ), which metabolize it into reactive intermediates such as derivatives capable of forming adducts with cellular macromolecules. Additionally, OTA directly inhibits mitochondrial function by disrupting complexes, particularly at low concentrations, leading to reduced ATP production and uncoupling of . The acute oral LD50 of OTA in rats is approximately 20-22 mg/kg body weight, reflecting its potency in eliciting these biochemical disruptions. Ochratoxin A (OTA) primarily targets the kidneys, where it accumulates in epithelial cells due to via organic anion transporters, leading to degeneration characterized by , DNA damage, and through pathways such as PTEN/AKT and ERK1/2. This degeneration manifests as cellular and impaired function, including reduced secretory capacity for organic anions and endocytic uptake of proteins like . Chronic exposure further promotes renal via epithelial-to-mesenchymal transition (EMT), with upregulation of transforming growth factor-β (TGF-β), α-smooth muscle actin (α-SMA), and tissue inhibitor of metalloproteinase-1 (TIMP-1), resulting in increased deposition (up to 244% in ) and extracellular matrix accumulation. Additionally, OTA reduces (GFR) by altering renal , such as increasing efferent arteriolar resistance and decreasing renal blood flow, which collectively impair overall function. OTA has been associated with human nephropathies, particularly (BEN), a chronic tubulointerstitial disease prevalent in rural areas along the River tributaries in the , and chronic interstitial nephropathy in other regions. In BEN patients, serum OTA levels have been reported as elevated, with medians around 1.15 ng/mL (range 0.4–3.9 ng/mL), higher than in controls. Urinary OTA levels in endemic areas are generally low, with means around 0.007 ng/mL (range up to 0.86 ng/mL). In serum of Polish patients with chronic renal failure on dialysis, including those with interstitial nephropathy, OTA was detected in 95% with mean 52.7 ng/mL (maximum 62.8 ng/mL). However, remains debated, as recent reviews emphasize a multifactorial etiology for BEN, with from plants identified as the primary cause, while OTA may act as a contributing or synergistic factor rather than the sole agent. In animal models, the serves as a sensitive indicator of OTA , mirroring human in conditions like Danish porcine nephropathy. Pigs exposed to OTA exhibit histopathological changes including proximal tubular , , and reduced concentrating ability, with effects observable at chronic low doses that impair postproximal function and handling. These findings underscore the organ's vulnerability, as OTA concentrations in kidneys can reach levels 6.25 times higher than in controls after intoxication. Epidemiological data link OTA exposure to renal diseases in regions with high cereal contamination, such as the , where grains like and often exceed OTA thresholds due to and growth under humid conditions. Studies show correlations between dietary OTA intake from contaminated cereals and elevated biomarkers in affected populations, but establishing direct is complicated by confounding factors like genetic susceptibility and co-exposures, as highlighted in 2021 reviews questioning OTA's primacy in BEN etiology.

Carcinogenicity

Ochratoxin A (OTA) was classified by the International Agency for Research on Cancer (IARC) in 1993 as a Group 2B carcinogen, indicating it is possibly carcinogenic to humans, based primarily on sufficient evidence of carcinogenicity in experimental animals. As of 2024, this classification remains unchanged, with the EFSA's 2020 opinion reaffirming genotoxic concerns without revising tolerable intake due to data limitations. This classification stems from studies demonstrating OTA's ability to induce renal tumors in following . In animal models, OTA consistently promotes renal carcinogenesis, particularly in rats, where dietary exposure leads to the development of renal cell adenomas and carcinomas. For instance, in male Fischer 344 rats administered OTA by gavage at doses of 21, 70, or 210 μg/kg body weight for two years, renal tumor incidence increased dose-dependently, reaching up to 72% (adenomas and carcinomas combined) at the highest dose of 210 μg/kg. Similar findings in other rat studies report tumor incidences ranging from 20% to 80% at dietary concentrations of 5 mg/kg, highlighting OTA's potent nephrocarcinogenic effects in males, who are more susceptible than females. The proposed mechanism involves oxidative metabolism of OTA to its hydroquinone derivative (OTHQ), which autoxidizes to a quinone (OTQ) intermediate capable of forming DNA adducts, such as the OTB-deoxyguanosine adduct, thereby contributing to genotoxic damage. Regarding genotoxicity, OTA exhibits indirect mutagenic potential, testing negative in the Ames assay without metabolic activation but positive when rat liver microsomes or transition metals (e.g., Fe(III)) are present, indicating bioactivation is required for DNA interaction. In humans, epidemiological evidence links OTA exposure to increased risk of urinary tract tumors, particularly in regions affected by (BEN), where OTA levels in blood were detectable in 26.7% of patients with BEN or urinary tract tumors versus 12.1% in healthy endemic controls. Systematic reviews of such studies report unadjusted odds ratios of approximately 2-3 for associations between OTA exposure and BEN or upper urinary tract cancers, though results are often not statistically significant due to factors like co-exposures.

Other Toxic Effects

Ochratoxin A (OTA) exhibits neurotoxic effects beyond its primary renal impacts, primarily through disruption of systems and induction of in the . In models, OTA interferes with glutamate uptake by downregulating transporters such as GLT-1 in , leading to and impaired . This disruption contributes to dopaminergic dysfunction, as evidenced by acute depletion of and its metabolites in the of exposed mice. Behavioral alterations, including reduced locomotion and motor impairment, have been observed in male mice following subchronic oral exposure to OTA at doses of 0.21–0.5 mg/kg, with effects persisting for up to six months post-treatment. The immunotoxic potential of OTA manifests as suppression of key immune responses, increasing vulnerability to pathogens in animal models. OTA inhibits T-cell proliferation by depleting cellular ATP and downregulating signaling pathways such as and in murine splenocytes at concentrations as low as 10 ng/mL . This leads to impaired adaptive immunity, including reduced production; for instance, in chicks fed OTA at 0.5–2 mg/kg in the diet, IgY and IgG titers against sheep red blood cells were significantly lowered by day 14 post-immunization. Consequently, exposed animals show heightened susceptibility to infections, such as exacerbated E. coli colonization and Newcastle disease in chickens administered 0.1–1.5 mg/kg OTA in feed, due to diminished NK cell activity and induction. OTA also induces hepatotoxicity characterized by oxidative damage and inflammatory responses in the liver, often marked by elevated serum enzymes. In rats, subacute exposure to OTA via oral gavage elevates levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicative of hepatocellular injury, with protective agents like silymarin mitigating these increases. Teratogenic effects further highlight OTA's developmental toxicity, particularly in rodents, where single oral doses around 2.75 mg/kg body weight during gestational days 6–7 in Wistar rats cause fetal skeletal malformations, including defects in sternebrae, vertebrae, and ribs, alongside visceral anomalies like renal hypoplasia. These outcomes stem from OTA's inhibition of protein synthesis, a mechanism that broadly underlies its toxic profile. Evidence for endocrine disruption by OTA remains limited but suggests interference with hormone biosynthesis rather than direct receptor binding. In human adrenocortical H295R cells, OTA at 1000 ng/mL upregulates expression, resulting in elevated production without agonistic or strong antagonistic effects on steroid receptors. This alteration in steroidogenesis has been linked to reproductive impairments in rats, though further studies are needed to clarify its physiological relevance.

Exposure Assessment

Routes of Exposure

The primary route of exposure to ochratoxin A (OTA) for humans and animals is dietary intake, occurring through the consumption of contaminated food and feed such as cereals, coffee, wine, dried fruits, and pork products. This pathway accounts for the majority of overall exposure in the general population, with OTA being rapidly absorbed from the gastrointestinal tract into the bloodstream. Inhalation represents a minor route, primarily relevant in occupational settings such as grain handling, agriculture, or waste management, where workers may inhale dust containing OTA produced by molds like Aspergillus and Penicillium species. Case reports have linked acute inhalation exposure, such as during prolonged granary work, to symptoms including renal failure, though such incidents are rare and recovery is possible with supportive care. Dermal exposure occurs through direct skin contact with moldy materials or contaminated dust, but it is of low significance due to limited absorption and . Studies indicate that OTA can penetrate , though no substantial health risks are typically associated with this route in agricultural or domestic settings. Additional exposure pathways include maternal transfer to offspring. OTA crosses the , with detectable levels found in blood, sometimes exceeding maternal concentrations, as observed in studies from regions with high dietary contamination. In lactating individuals, OTA is excreted into , exposing nursing infants to levels ranging from traces to over 100 ng/L depending on maternal intake. Similar transfer has been documented in animals via . Due to its high affinity for serum albumin, OTA exhibits significant bioaccumulation in the body, particularly in the kidneys, leading to chronic low-level exposure even after intermittent intake. In humans, the plasma half-life is approximately 35 days following oral exposure, far longer than in most other species, which contributes to its persistence and potential for cumulative effects.

Human and Animal Intake Levels

Human dietary exposure to ochratoxin A (OTA) primarily occurs through contaminated , with average chronic levels in estimated at 0.6–2.1 ng/kg body weight per day for adults and higher for children and infants (0.9–5.1 ng/kg body weight per day). High-percentile (95th) exposures reach 1.2–4.9 ng/kg body weight per day in adults and up to 11.9 ng/kg body weight per day in younger populations, based on occurrence data from cereals, , wine, and other commodities. In high-risk regions, such as areas affected by , levels have historically been elevated, reaching up to 15 ng/kg body weight per day due to persistent contamination in staple like grains and products. Among animals, pigs exhibit the highest sensitivity to OTA among animals, with the Joint FAO/WHO Expert Committee on Food Additives (JECFA) establishing a provisional tolerable weekly (PTWI) of 100 ng/kg body weight for humans, derived from renal effects observed in porcine studies. In contrast, and ruminants like are less susceptible, as OTA undergoes substantial degradation in the rumen—primarily by and —to the less toxic ochratoxin α, reducing and mitigating nephrotoxic risks. This species-specific highlights why monogastric animals like pigs face greater exposure challenges compared to herbivores. A 2023 EFSA assessment concluded that risks to animal health from OTA in feed are low for pigs, chickens for fattening, laying hens, and rabbits at observed exposure levels. Risk assessments for OTA employ the margin of exposure (MOE) approach, particularly for , where the benchmark dose lower confidence limit (BMDL10) for non-neoplastic renal effects in pigs is 4.73 μg/kg body weight per day, yielding an MOE of approximately 10,000 relative to typical human exposures of 0.5–1 ng/kg body weight per day, indicating low concern but warranting continued monitoring. relies on detecting OTA in (typically 0.013–110 ng/L) and serum (0.15–18 ng/L), which correlate with dietary intake and provide of internal exposure in both humans and animals. In , OTA contamination leads to notable industry impacts, particularly in production, where feed levels of 1 mg/kg can reduce growth rates by 5–12% through impaired feed efficiency and weight gain, alongside increased susceptibility to secondary infections. These effects contribute to broader economic losses in production, estimated in the millions annually due to decreased carcass quality, higher veterinary costs, and rejected batches from residue carryover into .

Detection and Analysis

Analytical Methods

The detection and quantification of ochratoxin A (OTA) in food and feed samples require robust analytical methods to ensure accuracy, , given its low regulatory limits and complex matrices such as cereals, , and wine. is a critical step, typically involving extraction with methanol-water mixtures (e.g., 80:20 v/v) to solubilize OTA from the matrix, followed by filtration and dilution to minimize interferences. Cleanup is often achieved using immunoaffinity columns (IAC), which selectively bind OTA via antibodies, enabling with methanol for purer extracts and reducing matrix effects in subsequent analysis. This approach has been validated for various commodities, including roasted and , where it enhances recovery rates to 80-110%. Instrumental methods dominate confirmatory analysis due to their precision. with fluorescence detection (HPLC-FLD) is a standard technique, employing reversed-phase columns and excitation at 333 nm/emission at 460 nm to detect OTA's native , achieving limits of detection () as low as 0.1 µg/kg in matrices like grains and dry-cured meats. For enhanced specificity and multi-mycotoxin screening, liquid chromatography-tandem (LC-MS/MS) is preferred, using in negative mode to confirm OTA identity via multiple reaction monitoring, with LODs below 0.1 µg/kg and the ability to quantify over 90 mycotoxins simultaneously in complex samples. These methods comply with international validation protocols, ensuring across laboratories. Rapid screening tests provide quick, on-site alternatives for high-throughput monitoring. Enzyme-linked immunosorbent assay (ELISA) kits utilize competitive antibody binding to OTA, offering sensitivity around 0.5 µg/kg in grains and feeds, with results obtainable in under 2 hours and suitable for preliminary assessments before instrumental confirmation. Emerging biosensors, particularly aptamer-based designs, leverage single-stranded DNA or RNA aptamers that specifically recognize OTA, enabling label-free or electrochemical detection with LODs in the ng/mL range; for instance, structure-switching aptamer platforms integrated with lateral flow devices allow instrument-free readout in minutes for food samples. These innovations improve portability and reduce costs compared to traditional immunoassays. Method validation follows and ISO standards to guarantee reliability. , for example, outlines HPLC-FLD procedures for OTA in roasted , specifying recovery, precision, and criteria, while ISO 15141-1 and -2 provide guidelines for LC-based detection in foodstuffs at levels above 0.2-3 µg/kg. Recent advances include portable near-infrared (NIR) spectroscopy, which uses chemometric models like partial to non-destructively screen OTA in , with potential for prediction accuracies over 90% and around 1 µg/kg through integration with . These spectroscopic tools facilitate real-time monitoring in agricultural settings without sample destruction.
MethodTypeLOD (µg/kg)AdvantagesLimitationsReference
HPLC-FLDInstrumental0.1High sensitivity, routine useRequires cleanup, lab-based
LC-MS/MSInstrumental<0.1Confirmation, multi-analyteExpensive equipment
Rapid screening0.5Quick, cost-effectiveSemi-quantitative, matrix effects
Aptamer-based Rapid/emerging0.01-0.1Portable, specificEmerging validation
Portable NIREmerging~1Non-destructive, on-siteCalibration needed

Regulatory Limits

The has established maximum levels for ochratoxin A (OTA) in various foodstuffs through Commission Regulation (EU) 2023/915, which updated and consolidated previous measures under Regulation (EC) No 1881/2006, effective from May 2023. These levels range from 0.50 µg/kg in baby foods and processed -based foods for infants to 5.0 µg/kg in unprocessed grains, with 3.0 µg/kg for most derived products; for wine and intended for direct consumption, the limit is 2.0 µg/L. Higher thresholds apply to certain commodities like dried vine fruits (8.0 µg/kg), pistachios for final use (5.0 µg/kg), and spices such as spp. (20 µg/kg), reflecting considerations of typical contamination patterns and dietary exposure risks. The Commission recommends maximum levels for OTA aligned with international trade needs, including 5 µg/kg in raw cereal grains as a guideline to protect consumer health while facilitating global commerce. For , references general principles in standard CXS 193-1995, but specific limits such as 100–250 µg/kg in complete feed (e.g., 100 µg/kg for , 250 µg/kg for pigs) are adopted from regional frameworks like the to prevent carryover into food products. In the United States, the (FDA) does not enforce binding regulatory limits for OTA in food or feed but relies on guidance levels and monitoring to ensure safety, evaluating contaminants under the Federal Food, Drug, and Cosmetic Act. The FDA's Mycotoxins in Domestic and Imported Human Foods Compliance Program, updated in September 2024, targets OTA in grains, , dried fruits, and other susceptible commodities through sampling and analysis to support risk assessments and import refusals when levels pose health concerns. The World Health Organization's Joint FAO/WHO Expert Committee on Food Additives (JECFA) established a provisional tolerable weekly (PTWI) of 100 ng/kg body weight for OTA in 2007, reaffirmed in subsequent evaluations as a benchmark for dietary exposure. National monitoring efforts, such as the FDA's ongoing surveys, demonstrate high compliance in imported goods, with recent data indicating that OTA detections rarely exceed advisory thresholds in regulated commodities like cereals and . These regulatory frameworks emphasize prevention through analytical detection methods to enforce limits and minimize risks from OTA exposure.
Region/OrganizationKey CommodityMaximum Level
EU (Regulation (EU) 2023/915)Unprocessed cereals5.0 µg/kg
EU (Regulation (EU) 2023/915)Cereal-derived products3.0 µg/kg
EU (Regulation (EU) 2023/915)Wine2.0 µg/L
Codex AlimentariusRaw cereal grains5 µg/kg (guideline)
US FDAGrains (guidance, no binding limit)Monitored; action if unsafe
WHO JECFADietary intake (PTWI)100 ng/kg bw/week

Prevention and Control

Decontamination Strategies

Decontamination strategies for ochratoxin A (OTA) aim to remove or degrade the toxin from contaminated and feed materials post-harvest, focusing on physical, chemical, and biological approaches to minimize risks while preserving product quality. These methods target OTA's , including its amide bond and lactone ring, but often result in partial reduction rather than complete elimination due to the toxin's stability. Efficacy varies by matrix, such as grains, , or wine, and conditions like temperature, , and exposure time. Physical methods include sorting visibly contaminated materials, treatments, and . Sorting damaged grains or fruits can reduce OTA levels by removing high-contamination sources, though it is labor-intensive and incomplete. processing, such as green beans at 200°C for 3-10 minutes, achieves 50-90% OTA reduction depending on roast intensity and bean type, with higher temperatures promoting degradation but risking flavor loss. Gamma at doses of 10-20 kGy degrades OTA by 50-61% in grains and dried fruits via free radical formation, following kinetics, while UV-C or beams offer similar matrix-dependent reductions of up to 96% under optimized conditions. These techniques are non-residual but may alter nutritional profiles or sensory attributes, limiting their use in sensitive products. Adsorption using physical agents like or natural sorbents (e.g., stems) binds OTA in liquids such as wine, achieving 87-100% removal at neutral pH, though non-specific binding can deplete beneficial compounds. Emerging nanotechnology-based adsorbents, including -alginate nanogels and nano-clays like , enhance specificity; for instance, nanoparticles with essential oils reduce OTA adsorption in stored grains by 70-90% while inhibiting fungal growth. Limitations include potential sequestration and variable efficiency in complex matrices. Chemical methods involve agents that hydrolyze or oxidize OTA. Alkaline hydrolysis with or (2-5% at 90°C for 30-60 minutes) targets the bond, reducing OTA by 50-83% in grains and , producing less toxic derivatives. Ozonation exposes materials to gas (20-60 ppm) or aqueous solutions, degrading 65-95% of OTA in maize and corn within 1-2 hours at 25°C by cleaving the ring, with higher concentrations yielding better results. Ammoniation, using gas at 50-80°C and 20-30% moisture for several days, historically achieves up to 90% reduction in grains like and but is largely abandoned due to off-flavors, nutritional degradation, and residual concerns. These methods are effective for bulk commodities but require careful residue management to avoid new safety issues. Biological methods leverage microorganisms or enzymes for targeted degradation. Bacteria such as and species degrade OTA via adsorption to cell walls or enzymatic , reducing levels by 70-100% in fermented products like wine and grains over 24-72 hours, with strains producing iturin A or carboxypeptidase enhancing . Yeast cell walls adsorb OTA in beverages, achieving 80-90% removal, while purified enzymes like ochratoxinase or alcohol dehydrogenase 3 (ADH3) fully degrade OTA in seconds to minutes under mild conditions (e.g., pH 7, 37°C). Biological approaches are eco-friendly but can introduce off-tastes or require strain optimization. Overall, no single method fully eliminates OTA without compromising quality, with reductions typically ranging from 50-95% across techniques; combined approaches, such as ozonation followed by biological treatment, show promise for higher efficacy. Limitations include cost, regulatory approval for residues, and matrix-specific performance, underscoring the need for integrated strategies informed by OTA's thermal stability up to 180°C. Ongoing into nanotechnology-based adsorbents aims to address these gaps for safer chains.

Management in Agriculture

Effective management of ochratoxin A (OTA) in emphasizes preventive strategies during pre-, , and storage phases to limit fungal growth by and species, thereby reducing contamination risks in crops like cereals, , and grapes. These approaches integrate good agricultural practices (GAP) with targeted interventions to address environmental factors such as humidity and temperature, which favor OTA production, as reaffirmed in recent FAO guidelines as of 2020. Pre-harvest strategies focus on minimizing through cultural and chemical controls. , such as avoiding consecutive planting of susceptible cereals, disrupts pathogen buildup in soil and reduces prevalence. Breeding and selection of resistant varieties, including low-OTA-accumulating cultivars like those derived from quantitative trait loci (QTL) mapping for fungal resistance, enhance crop resilience without relying solely on inputs. applications, particularly (e.g., Quadris®), applied during critical growth stages, inhibit carbonarius infection in vineyards and cereals, achieving up to 96.5% OTA reduction when integrated into programs. At harvest and storage, rapid intervention prevents post-harvest proliferation of OTA-producing fungi. Grains and beans must be dried immediately to below 14% content using hot-air systems or thin-layer sun drying to inhibit Penicillium verrucosum and growth, with targets of <12.5% for . in storage facilities cools grain to below 10°C promptly, using rates of 10–180 m³/hour per to maintain low temperatures and prevent , while hermetic silos with sealed designs exclude and pests. Implementing Hazard Analysis and Critical Control Point (HACCP) protocols identifies risks like ingress, ensuring cleaning of equipment and monitoring to avoid carryover contamination. Good agricultural practices further mitigate OTA by addressing handling and environmental stressors. Regular monitoring of and during cultivation and storage, combined with gentle handling to prevent physical damage that invites fungal entry, forms the basis of effective control. Amid global warming, which expands OTA-prone regions through warmer, wetter conditions favoring at 25–30°C and high , climate-resilient strategies include optimized , stress-resistant varieties, and adaptive to sustain yields and safety. Global initiatives promote standardized prevention through authoritative guidelines and integrated approaches. The (FAO) provides codes of practice, such as CAC/RCP 69-2009 for and CAC/RCP 51-2007 for cereals, advocating GAP, timely harvest, and moisture management to limit OTA below regulatory thresholds. (IPM), incorporating biological agents like Trichoderma spp. alongside selective fungicides, reduces Aspergillus spread in fields and storage, as demonstrated in vineyard trials achieving 69–91% OTA inhibition.

Genetic Factors

Resistance in Organisms

Animals exhibit varying degrees of resistance to ochratoxin A (OTA) primarily through physiological and microbial mechanisms in the . Ruminants, such as and sheep, demonstrate high resistance due to efficient degradation of OTA by ruminal microbiota, where play a central role in hydrolyzing the bond to form the non-toxic metabolite ochratoxin α (OTα). This process achieves up to 90% degradation within hours, with in vitro half-lives ranging from 0.4 to 1.2 hours, rendering ruminants far less susceptible than species. In contrast, pigs are highly susceptible, with minimal degradation by , leading to prolonged OTA absorption and at lower doses compared to other livestock. Chickens show intermediate resistance, partly attributed to that partially degrade OTA, though less efficiently than in ruminants, resulting in lower overall toxicity risks for under typical exposure levels. Plants develop resistance to OTA through breeding strategies targeting defenses against ochratoxigenic fungi like and species. In , conventional breeding focuses on enhancing pathogenesis-related (PR) proteins, such as PR-1 and PR-10 families, which exhibit activity by disrupting fungal cell walls and inhibiting , thereby reducing pre-harvest colonization and potential OTA production. These PR proteins are induced during fungal attack and contribute to durable resistance without directly targeting the itself. Microbial resistance to OTA often involves mechanisms that either degrade the toxin or prevent its uptake. , such as Lactobacillus plantarum, degrade OTA through enzymatic action, primarily via intracellular esterases and peptidases that cleave the amide bond, achieving up to 80% reduction in synthetic media within hours. This process is strain-specific and enhances applications like bio- in fermented products. Additionally, some employ efflux pumps, such as ATP-binding cassette (ABC) transporters, to expel OTA from cells, conferring intrinsic resistance by maintaining low intracellular concentrations and avoiding toxicity. These mechanisms are widespread in gut-associated microbes, supporting their role in animal resistance. Recent genetic research has advanced understanding of OTA resistance through quantitative trait locus (QTL) mapping in . Studies in lines have identified QTL regions on chromosomes associated with reduced OTA-induced , linking variations in composition and enzyme expression to enhanced degradation efficiency. A 2023 investigation highlighted key QTLs influencing OTA tolerance in chickens, paving the way for in breeding programs to improve resilience in commercial flocks.

Human Susceptibility

Human susceptibility to ochratoxin A (OTA) is influenced by genetic polymorphisms that affect detoxification pathways, particularly in the context of Balkan endemic nephropathy (BEN), a chronic renal disease associated with OTA exposure. Variations in glutathione S-transferase (GST) genes, such as GSTA1, have been linked to increased risk; carriers of the GSTA1*B allele exhibit a 1.6-fold higher odds of BEN compared to those with the homozygous *A/*A genotype (OR = 1.6, p = 0.037), likely due to impaired biotransformation of OTA into less toxic conjugates like OTHQ-SG and OTB-SG. Similarly, polymorphisms in GSTM1 (null genotype) and GSTT1 (active genotype) are associated with greater OTA-induced DNA damage in urothelial cells, elevating susceptibility to urinary bladder cancer in BEN-endemic areas, where the cancer risk is up to 90-fold higher than in non-endemic regions. Certain human leukocyte antigen (HLA) haplotypes, including A3-B27/35-DR7, confer heightened sensitivity to OTA, promoting chronic interstitial nephropathy with tubular karyomegalic changes in exposed individuals, while others with comparable exposure remain unaffected. Age and underlying conditions further modulate vulnerability to OTA's nephrotoxic effects, as the primarily targets the kidneys and persists due to its long half-life of approximately 35 days in humans. Children, particularly infants, face elevated exposure through (OTA levels 0.002–13.1 ng/mL) and exhibit higher intake estimates (median 1.7–2.6 ng/kg body weight/day), potentially leading to immature renal function impairment and biomarkers like elevated urinary β2-microglobulin (260 ± 162.5 μg/L). The elderly are more susceptible owing to age-related decline in renal clearance, exacerbating OTA accumulation and toxicity in those with reduced glomerular filtration rates. Comorbidities such as and amplify risks, as OTA exposure correlates with higher plasma levels in patients with chronic interstitial nephropathy (1.25 ± 1.22 ng/mL vs. 0.49 ± 0.67 ng/mL in healthy controls), and rising prevalence may interact with OTA to worsen renal outcomes. Population-level differences in OTA susceptibility are evident, particularly in Balkan regions where BEN prevalence is high and linked to chronic low-level exposure. Biomonitoring reveals higher OTA detection in Balkan populations, with urinary levels up to 1910 ng/L and 33% positivity rates, compared to global medians of 0.15–1.098 ng/mL in plasma; this variability underscores genetic and environmental factors like HLA-DRB1 alleles that may impair immune responses to OTA-induced damage. In contrast, non-endemic areas show lower urinary excretion (0.009–0.46 ng/mL mean), though extreme values occur in high-exposure settings like (up to 1.43 ng/mL). Epidemiological studies indicate no broad genetic resistance to OTA in humans, with interindividual detoxification variability contributing to diverse outcomes; however, dietary patterns that limit contaminated food intake can mitigate exposure and modulate effective susceptibility across populations. While associations exist between OTA and renal diseases like (OR up to 10.79 for in high-exposure cohorts), causality remains unproven due to factors, emphasizing the role of biomarkers like urinary OTA and OTα for assessing personalized risk.

References

  1. https://www.who.int/news-room/fact-sheets/detail/mycotoxins
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC4247821/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC4963825/
  4. https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2020.6113
  5. https://www.efsa.europa.eu/en/efsajournal/pub/6113
  6. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32022R1370
  7. https://pubmed.ncbi.nlm.nih.gov/37755991/
  8. https://pubchem.ncbi.nlm.nih.gov/compound/Ochratoxin-A
  9. https://pubchem.ncbi.nlm.nih.gov/compound/Ochratoxin-B
  10. https://pubchem.ncbi.nlm.nih.gov/compound/Ochratoxin-C
  11. https://www.ncbi.nlm.nih.gov/books/NBK513594/
  12. https://www.sigmaaldrich.com/US/en/product/sigma/o1877
  13. https://www.mdpi.com/2072-6651/2/4/461
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC3153212/
  15. https://www.sciencedirect.com/science/article/pii/S0362028X22077675
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC10534725/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC3153227/
  18. https://www.mdpi.com/2072-6651/8/4/111
  19. https://www.nature.com/articles/2051112a0
  20. https://pubmed.ncbi.nlm.nih.gov/5833211/
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC3153233/
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC4810228/
  23. https://www.mdpi.com/2072-6651/8/3/83
  24. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0078285
  25. https://www.tandfonline.com/doi/full/10.1080/02652030500412154
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC6146979/
  27. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2020.581309/full
  28. https://www.sciencedirect.com/science/article/pii/S0269749122019819
  29. https://www.sciencedirect.com/science/article/pii/S1382668911001001
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC9415321/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC5941014/
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC3153260/
  33. https://pubmed.ncbi.nlm.nih.gov/10447951/
  34. https://www.sciencedirect.com/science/article/pii/S0041008X00989877
  35. https://www.mdpi.com/2072-6651/9/4/113
  36. https://www.sciencedirect.com/science/article/pii/S092544390200159X
  37. https://academic.oup.com/toxsci/article/59/1/59/1658781
  38. https://pubmed.ncbi.nlm.nih.gov/5441684/
  39. https://www.sciencedirect.com/science/article/pii/0015626468901387
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC8539333/
  41. https://pubmed.ncbi.nlm.nih.gov/8956233/
  42. https://molmed.biomedcentral.com/articles/10.2119/2005-00038.Gagliano
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC5065591/
  44. https://www.mdpi.com/2072-6651/2/4/780
  45. https://www.sciencedirect.com/science/article/pii/S0041010121002130
  46. https://hal.science/hal-03482000v1/preview/Castegnaro_1258.pdf
  47. https://www.sciencedirect.com/science/article/abs/pii/S004101011730209X
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC11049263/
  49. https://www.inchem.org/documents/iarc/vol56/13-ochra.html
  50. https://www.sciencedirect.com/science/article/pii/S2405844024153443
  51. https://journals.sagepub.com/doi/10.1177/019262339202000210
  52. https://ntp.niehs.nih.gov/sites/default/files/ntp/htdocs/lt_rpts/tr358.pdf
  53. https://www.sciencedirect.com/science/article/abs/pii/S0378427498003476
  54. https://www.mdpi.com/2072-6651/4/4/267
  55. https://publications.iarc.who.int/_publications/media/download/1919/b0072031460902e5aace2461caae67f12e6a1ed9.pdf
  56. https://pmc.ncbi.nlm.nih.gov/articles/PMC12197389/
  57. https://onlinelibrary.wiley.com/doi/10.1155/2021/9967334
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC12115609/
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC10534339/
  60. https://pubmed.ncbi.nlm.nih.gov/16781114/
  61. https://doi.org/10.3390/toxins11070377
  62. https://pubmed.ncbi.nlm.nih.gov/23296098/
  63. https://www.sciencedirect.com/science/article/abs/pii/S089062381300052X
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC3255309/
  65. https://pubmed.ncbi.nlm.nih.gov/22749975/
  66. https://www.redalyc.org/journal/919/91967023005/html/
  67. https://www.mdpi.com/2072-6651/12/12/758
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC4848637/
  69. https://pubmed.ncbi.nlm.nih.gov/10849253/
  70. https://ec.europa.eu/food/fs/sc/scf/out14_en.html
  71. https://apps.who.int/food-additives-contaminants-jecfa-database/chemical.aspx?chemID=1905
  72. https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2023.8375
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC3153269/
  74. https://www.efsa.europa.eu/en/efsajournal/pub/8375
  75. https://www.mdpi.com/2072-6651/8/7/191
  76. https://www.mdpi.com/2072-6651/2/7/1796
  77. https://eaglebio.com/wp-content/uploads/2014/06/BTOT312005_Ochratoxin_Immunoaffinity_Column_HPLC_Package_Insert.pdf
  78. https://www.agilent.com/cs/library/applications/5991-2854EN.pdf
  79. https://joint-research-centre.ec.europa.eu/system/files/2015-09/49205%252520-%252520eur%25252023657%252520-%252520ochratoxin%252520a%252520in%252520animal%252520feed.pdf
  80. https://www.sciencedirect.com/science/article/pii/S2215016120300923
  81. https://www.nature.com/articles/s41598-018-20534-7
  82. https://www.cusabio.com/uploadfile/Ins/2020-06-17/CSB-EFD027449.pdf
  83. https://pmc.ncbi.nlm.nih.gov/articles/PMC11356850/
  84. https://www.mdpi.com/1420-3049/28/24/8135
  85. https://www.aoac.org/wp-content/uploads/2021/12/SMPR-2021_010.pdf
  86. https://www.spectroscopyonline.com/view/new-ai-strategy-for-mycotoxin-detection-in-cereal-grains
  87. https://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX:32023R0915
  88. https://www.fao.org/fao-who-codexalimentarius/sh-proxy/en/?lnk=1&url=https%253A%252F%252Fworkspace.fao.org%252Fsites%252Fcodex%252FStandards%252FCXS%2B193-1995%252FCXS_193e.pdf
  89. https://www.fda.gov/food/natural-toxins-food/mycotoxins
  90. https://www.fda.gov/media/140749/download
  91. https://www.fda.gov/food/hfp-constituent-updates/fda-updates-mycotoxins-domestic-and-imported-human-foods-compliance-program
  92. https://www.mdpi.com/2072-6651/15/9/565
  93. https://www.sciencedirect.com/science/article/pii/S0956713513002971
  94. https://www.hillpublisher.com/ArticleDetails/5025
  95. https://www.sciencedirect.com/science/article/pii/S2590259825000184
  96. https://www.mdpi.com/2304-8158/13/8/1184
  97. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2018.01386/full
  98. https://pmc.ncbi.nlm.nih.gov/articles/PMC3153271/
  99. https://www.fao.org/input/download/standards/11250/CXP_069e.pdf
  100. https://www.fao.org/input/download/standards/406/CXP_051e_2014.pdf
  101. https://doi.org/10.3390/toxins13100725
  102. https://pmc.ncbi.nlm.nih.gov/articles/PMC11679220/
  103. https://wgrf.ca/wp-content/uploads/2018/07/Preventing-Contaminated-Grain-Ochratoxin-A-Final.pdf
  104. https://www.food.gov.uk/sites/default/files/media/document/ochratoxinacop.pdf
  105. https://pmc.ncbi.nlm.nih.gov/articles/PMC10379110/
  106. https://pmc.ncbi.nlm.nih.gov/articles/PMC3153210/
  107. https://pmc.ncbi.nlm.nih.gov/articles/PMC9330798/
  108. https://pmc.ncbi.nlm.nih.gov/articles/PMC4179162/
  109. https://openbiotechnologyjournal.com/VOLUME/12/PAGE/282/FULLTEXT/
  110. https://pmc.ncbi.nlm.nih.gov/articles/PMC4147586/
  111. https://www.sciencedirect.com/science/article/pii/S0300483X06002423
  112. https://pubmed.ncbi.nlm.nih.gov/16705817/
  113. https://pubmed.ncbi.nlm.nih.gov/28263864/
Add your contribution
Related Hubs
User Avatar
No comments yet.